Substituted pyrimidinyl derivatives and methods of use

Details Substituted pyrimidinyl derivatives and methods of use Substituted pyrimidinyl derivatives and methods of use

2005-09-06

2005-09-06

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S324000

Reexamination Certificate

active

06939874

ABSTRACT:
The invention encompasses compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions, uses and methods for prophylaxis and treatment of cancer.

REFERENCES:
patent: 2585910 (1952-02-01), Barton et al.
patent: 2585972 (1952-02-01), Stacey et al.
patent: 2585979 (1952-02-01), Vasey
patent: 2643253 (1953-06-01), Curd et al.
patent: 4983608 (1991-01-01), Effland et al.
patent: 5043317 (1991-08-01), Chapman et al.
patent: 5935966 (1999-08-01), Suto et al.
patent: 5958935 (1999-09-01), Davis et al.
patent: 6080858 (2000-06-01), Schumacher
patent: 0 379 806 (1996-04-01), None
patent: 0 945 443 (1999-09-01), None
patent: 1 040 831 (2000-10-01), None
patent: 794043 (1958-04-01), None
patent: WO 94/26733 (1994-11-01), None
patent: WO 95/33750 (1995-12-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 98/41512 (1998-09-01), None
patent: WO 99/31073 (1999-06-01), None
patent: WO 99/41253 (1999-08-01), None
patent: WO 99/50250 (1999-10-01), None
patent: WO 00/27825 (2000-05-01), None
patent: WO 00/39101 (2000-07-01), None
patent: WO 00/53595 (2000-09-01), None
patent: WO 00/59892 (2000-10-01), None
patent: WO 00/78731 (2000-12-01), None
patent: WO 01/00213 (2001-01-01), None
patent: WO 01/19825 (2001-03-01), None
patent: WO 01/22938 (2001-04-01), None
patent: WO 01/29009 (2001-04-01), None
patent: WO 01/40218 (2001-06-01), None
patent: WO 01/47921 (2001-07-01), None
patent: WO 01/55116 (2001-08-01), None
patent: WO 01/60816 (2001-08-01), None
patent: WO 01/72717 (2001-10-01), None
patent: WO 01/72745 (2001-10-01), None
patent: WO 01/85700 (2001-11-01), None
patent: WO 02/22601 (2002-03-01), None
patent: WO 02/46170 (2002-06-01), None
patent: WO 02/46171 (2002-06-01), None
patent: WO 02/46184 (2002-06-01), None
patent: WO 02/47690 (2002-06-01), None
patent: WO 02/48147 (2002-06-01), None
patent: WO 02/48148 (2002-06-01), None
patent: WO 02/50065 (2002-06-01), None
patent: WO 02/50066 (2002-06-01), None
patent: WO 02/057259 (2002-07-01), None
patent: WO 02/059110 (2002-08-01), None
Girnita et al., Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor, PNAS, vol. 100, No. 14, pp. 8247-8252, 2003.
Romano, The complex biology of the Receptor for the Insulin-like Growth Factor-1, Drug News & Perspectives, Abstract, vol. 16, No. 8, Oct. 2003.
Khandwala et al., The Effects of Insulin-like Growth Factors on Tumorigenesis and Neoplastic Growth, Endocrine Reviews, 21 (3), pp. 215-244, 2000.
Ellis et al., Insulin-like Growth Factors in human breast cancer, Breast Cancer Research and Treatment 52:175-184, 1998.
Traxler, Review: Oncologic, Endocrine & Metabolic, Protein tyrosine kinase inhibitors in cancer treatment, Exp. Opin. Ther. Patents, 7(6), pp. 571-588, 1997.
Simone, Oncology: Introduction,Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1010, 1996.
Ghoneim et al., “Synthesis and Evaluation of Some 2-, 4-, and 2,4-Disubstituted-6-Methylpyrimidine Derivatives for Antimicrobial Activity” (1978) 28: 117-126.

Affiliated with

Also associated with

Rating

Substituted pyrimidinyl derivatives and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrimidinyl derivatives and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrimidinyl derivatives and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3394119